| Trial registration number
|
NCT05302973 |
Full text link
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05302973
|
First author
Last imported at : July 23, 2023, midnight
Source : ClinicalTrials.gov
|
None
|
Contact
Last imported at : July 23, 2023, midnight
Source : ClinicalTrials.gov
|
None
|
Registration date
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
2022-03-31
|
Recruitment status
Last imported at : July 23, 2023, midnight
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Long covid
|
Inclusion criteria
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
defined diagnosis of interstitial pneumonia due to covid-19;
two negative nasopharyngeal swab test for sars-cov-2;
functional independence before the covid-19;
mini-mental state examination (mmse) score > 24.
|
Exclusion criteria
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
positivity to covid-19;
patients living in a nursing home or not autonomous prior to the covid-19;
presence of moderate or severe heart disease (grade iii or iv, new york heart association);
presence of neurological disease;
low compliance;
patients with low rehabilitation needs (fim total score at admission >100)
terminal illness (life expectation <6 months)
|
Number of arms
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Istituti Clinici Scientifici Maugeri SpA
|
Inclusion age min
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Italy
|
Type of patients
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Patients recovered from covid
|
Severity scale
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
30
|
primary outcome
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Analysis of feasibility
|
Notes
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : April 1, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "nan", "treatment_id": 41, "treatment_name": "Aerobic exercise", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|